Delivery Order SPE2DB20D3104-SPE2DB22FV7J9
Award Date 6/9/22
Potential Completion Date 6/10/22
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Emtricitabine-Tenofv 200-300 mg medication. The award has a ceiling value of $1,399.07 and a completion date of November 13, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award is for the delivery of Emtricitabine-Tenofv 200-300mg medications to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a firm fixed price and a ceiling value of $1,247.79. It was awarded on January 31, 2024, with a period of performance through February 1, 2024. The contract is a delivery order and is not associated with a set-aside program. Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The $1,423.46 firm fixed-price delivery order covers the supply of 4,559,445,928 units of the pharmaceutical product Emtricitabine-Tenofv 200-300mg. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,096.64, is a Delivery Order contract for the procurement of Emtricitabine-Tenofovir 200-300mg medication, with a completion date of May 2, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award, valued at $4,034.75, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Emtricitabine-Tenofv 200-300mg medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,516.82, is for the delivery of emtricitabine-tenofv 200-300mg pharmaceutical products. It is a Firm Fixed Price Delivery Order contract with a completion date of September 26, 2023. The contract is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,066.17 firm fixed-price delivery order contract is for the supply of emtricitabine-tenofovir 200-300mg medication. The contract has an ultimate completion date of February 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,262.63 firm-fixed-price delivery order is for the supply of emtricitabine-tenofovir 200-300 mg prescription medications. The contract has a completion date of February 2, 2022 and was awarded on February 1, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,049.71 firm fixed-price delivery order, identified as SPE2DB20D1004|SPE2DB25FNGJU, is for the supply of Emtricitabine-Tenofv 200-300mg medication in 30-count units. The contract has an ultimate completion date of April 16, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $2,509.19, is for the delivery of Emtricitabine-Tenofovir 200-300 mg tablets under Delivery Order SPE2DB24FH38V. The contract has a completion date of November 17, 2023 and is a Firm Fixed Price (FFP) contract type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...